|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ABII 10-K filed Mar 12, 2010. Sales and Marketing We have dedicated sales and marketing groups in North America, Europe and China. In each of these regions, our team targets key segments of the oncology market: specifically, leading oncologists, cancer centers and the oncology distribution channel. In North America, our team consists of approximately 189 sales, marketing and medical affairs professionals. We continue to maintain our European infrastructure with an initial focus on five key European markets (United Kingdom, France, Spain, Italy and Germany). The sales and commercial services functions are provided by Quintiles Transnational Corp., which is the leading global commercial solutions provider to the pharmaceutical, biotech and medical device industries. We have medical representatives trained and deployed in the United Kingdom, Germany, Spain, Italy and France. In the second quarter of 2009, we launched Abraxane® in China, which has a team of approximately 51 employees including 46 medical representatives and managers. These excerpts taken from the ABII 10-K filed Mar 6, 2009. Sales and Marketing We have a dedicated sales and marketing group in North America which targets key segments of the oncology market: specifically, leading oncologists, cancer centers and the oncology distribution channel. This group is comprised of approximately 136 sales, marketing and medical professionals and support staff members. With respect to sales and marketing of Abraxane® in countries outside of North America, we are continuing to establish our infrastructure and are evaluating developing our own sales and marketing expertise as well as exploring possible strategic relationships for other jurisdictions. Sales force and commercial services in our European market will be provided by Innovex, a unit of Quintiles Transnational Corp., which is the leading global commercial solutions provider to the pharmaceutical, biotech, and medical device industries. Sales and Marketing oncology market: specifically, leading oncologists, cancer centers and the oncology distribution channel. This group is comprised of approximately 136 sales, marketing and medical professionals and support staff members. With respect to sales and marketing of Abraxane® in countries outside of North America, we are continuing to establish our infrastructure and are evaluating developing our own sales and marketing expertise as well as exploring possible strategic relationships for other jurisdictions. Sales force and commercial services in our European market will be provided by Innovex, a unit of Quintiles Transnational Corp., which is the leading global commercial solutions provider to the pharmaceutical, biotech, and medical device industries. This excerpt taken from the ABII 10-K filed Mar 31, 2008. Sales and Marketing We have a dedicated sales and marking group which targets key segments of the oncology market: specifically, leading oncologists, cancer centers and the oncology distribution channel. This group is comprised of approximately 180 sales, marketing and medical professionals and support staff members. In April 2006, we entered into a co-promotion and strategic marketing services agreement with AstraZeneca UK Limited to co-promote Abraxane® in the United States. Through this relationship, in addition to our already established sales force, AstraZeneca added an experienced sales force that solely co-promotes Abraxane® in the U.S. market. This commercial collaboration provides significantly greater reach and is expected to accelerate the market penetration of Abraxane® in the United States. With respect to sales and marketing of Abraxane® in countries outside of North America, we are continuing to establish our European infrastructure and are evaluating developing our own sales and marketing expertise as well as exploring possible strategic relationships for other jurisdictions.
15
Table of ContentsThis excerpt taken from the ABII 8-K filed Nov 8, 2007. Sales and Marketing We have a dedicated sales and marking group which targets key segments of the oncology market: specifically, leading oncologists, cancer centers and the oncology distribution channel. This group is comprised of approximately 165 sales, marketing and medical sales and support staff members. In April 2006, we entered into a co-promotion and strategic marketing services agreement with AstraZeneca UK Limited to co-promote Abraxane® in the United States. Through this relationship, in addition to our already established sales force, AstraZeneca added an experienced sales force that solely co-promotes Abraxane® in the U.S. market. This commercial collaboration provides significantly greater reach and is expected to accelerate the market penetration of Abraxane® in the United States. With respect to sales and marketing of Abraxane® in countries outside of North America, we are continuing to evaluate developing our own sales and marketing expertise as well as exploring possible strategic relationships. | EXCERPTS ON THIS PAGE:
|
| |||||||
